Quick answer
This page lists 21 autologous stem cell transplantation doctors in India. Review each doctor's experience, specialty and hospital, then contact our care team for help with the next step.
About Autologous Stem Cell Transplantation doctors in India
This directory is based on doctors currently listed in GAF Healthcare's registry. Clinical suitability varies by patient; a doctor should review your history and investigations before any treatment decision.
Autologous Stem Cell Transplantation doctors
FeaturedDr. Ashok Kumar Vaid
MBBS, MD (General Medicine), DM (Medical Oncology)
Chairman — Medical Oncology, Hematology & Stem Cell Transplant · Specialty: Medical Oncologist & BMT Specialist
Medanta - The Medicity Gurgaon, India44+ Years experience
Why consider this doctor?
- 44+ years of experience in Medical Oncologist & BMT Specialist
- Chairman — Medical Oncology, Hematology & Stem Cell Transplant, Medanta – The Medicity, Gurgaon (Present)
- Pioneered one of the largest stem cell transplant programmes in private-sector north India
Expertise & Procedures
- Allogeneic Stem Cell Transplant
- Autologous Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Bone Marrow Aspiration & Biopsy
- Chemotherapy Administration
Medical Oncologist & BMT Specialist Experience: 44+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Gaurav Dixit
MBBS, MD (General Medicine), DM (Clinical Haematology), Professional Certificate in Multiple Myeloma
Head — Haematology Oncology & Bone Marrow Transplant (Unit II) · Specialty: Hematologist & BMT Specialist
Artemis Hospital Gurgaon, India17+ Years experience
Why consider this doctor?
- 17+ years of experience in Hematologist & BMT Specialist
- Head — Haematology Oncology & Bone Marrow Transplant (Unit II), Artemis Hospital, Gurugram (Present)
- Senior Consultant — Haematology & BMT, Action Cancer Hospital, Delhi (~4 years)
Expertise & Procedures
- Autologous Stem Cell Transplant
- Matched Sibling Allogeneic Stem Cell Transplant
- Haploidentical Stem Cell Transplant
- Matched Unrelated Donor Transplant
- Bone Marrow Aspiration & Biopsy
Hematologist & BMT Specialist Experience: 17+ YearsHospital Affiliation: Artemis HospitalHospital accreditation: JCI, NABH
Dr. Vikas Dua
MBBS, MD (Paediatrics), FNB (Paediatric Hematology Oncology), Fellowship in Paediatric Bone Marrow Transplant, Outreach Programme in Paediatric BMT
Principal Director & Head — Paediatric Haematology, Haemato-Oncology & BMT · Specialty: Pediatric Hematologist & BMT Specialist
Fortis Memorial Research Institute Gurgaon, India20+ Years experience
Why consider this doctor?
- 20+ years of experience in Pediatric Hematologist & BMT Specialist
- Principal Director & Head — Paediatric Haematology, Haemato-Oncology and BMT, Fortis Memorial Research Institute, Gurgaon (Present)
- Senior Consultant — Paediatric Hemato-Oncology and BMT, Artemis Hospital, Gurgaon
Expertise & Procedures
- Allogeneic Bone Marrow Transplant
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Haploidentical Paediatric Stem Cell Transplant
- Autologous Stem Cell Transplant
Pediatric Hematologist & BMT Specialist Experience: 20+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Huma Noor
MBBS, MD (General Medicine), DM (Medical Oncology), MRCP — Medical Oncology
Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Escorts Heart Institute New Delhi, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Consultant — Medical Oncology, Fortis Escorts, Okhla Road, New Delhi (Present)
- Consultant — Medical Oncology, Fortis Escorts, Amritsar
Expertise & Procedures
- Chemotherapy Administration
- Immunotherapy Infusions
- Targeted & Hormonal Therapy
- Autologous Stem Cell Transplant
- Allogeneic Stem Cell Transplant (Paediatric & Adult)
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Fortis Escorts Heart InstituteHospital accreditation: JCI, NABH
Dr. Akshay Shah
MBBS, DNB, Fellowship in Stem Cell Transplantation
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Gleneagles Global Hospitals Mumbai, India22+ Years experience
Why consider this doctor?
- 22+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Gleneagles Global Hospitals, Mumbai — Present
- Specialist in Hematology and Bone Marrow Transplantation, Gleneagles Hospitals Parel, Mumbai
Expertise & Procedures
- Allogeneic and Autologous Stem Cell Transplantation
- Bone Marrow Aspiration and Biopsy
- Intrathecal Chemotherapy Injections
- Lumbar Puncture (Spinal Tap)
- Pleurodesis
Medical Oncologist Experience: 22+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Dr. Ashutosh Jain
MBBS, MD, DM
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Fortis Memorial Research Institute Gurgaon, India8+ Years experience
Why consider this doctor?
- 8+ years of experience in Medical Oncologist
- Associate Consultant, Department of Medical Oncology, Fortis Memorial Research Institute, Gurgaon — Present
- Medical Oncology Training and Clinical Practice, Tata Memorial Research Institute, Mumbai — Previous affiliation
Expertise & Procedures
- Chemotherapy for Solid Tumors
- Adjuvant Chemotherapy
- Neoadjuvant Chemotherapy
- Palliative Chemotherapy
- Immunotherapy for Solid Tumors
Medical Oncologist Experience: 8+ YearsHospital Affiliation: Fortis Memorial Research InstituteHospital accreditation: JCI, NABH
Dr. Joydeep Singh Vasant
MBBS, MD, DM, ESMO Certification
Associate Consultant — Medical Oncology · Specialty: Medical Oncologist
Medanta - The Medicity Gurgaon, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist
- Associate Consultant, Medical Oncology, Medanta - The Medicity, Gurgaon, Present
- Medical Oncology Specialist, Medanta - The Medicity, Gurgaon
Expertise & Procedures
- Chemotherapy Administration for Solid Tumors
- Adjuvant and Neoadjuvant Chemotherapy Planning
- Immunotherapy for Advanced Cancers
- Targeted Therapy Delivery and Management
- Hormone Therapy for Breast Cancer
Medical Oncologist Experience: 11+ YearsHospital Affiliation: Medanta - The MedicityHospital accreditation: JCI, NABH
Dr. Macha Kiran Kumar
MBBS, MD, DM, ECMO, FCR, PDCR
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Secunderabad Hyderabad, India13+ Years experience
Why consider this doctor?
- 13+ years of experience in Medical Oncologist
- Senior Consultant, Medical Oncology — Yashoda Hospitals, Secunderabad (Present)
- Consultant, Medical Oncology — Medicover Cancer Institute, Hitec City, Hyderabad
Expertise & Procedures
- Chemotherapy Administration and Management
- Cancer Immunotherapy and Checkpoint Inhibitors
- Targeted Molecular Therapy
- Hormone Therapy for Breast Cancer
- Autologous Stem Cell Transplantation
Medical Oncologist Experience: 13+ YearsHospital Affiliation: Yashoda Hospitals, SecunderabadHospital accreditation: NABH, NABL
Dr. Naidu N. Bethune
MBBS, MD, DM
Senior Consultant — Medical Oncology · Specialty: Medical Oncologist
Yashoda Hospitals, Hi-Tech City Hyderabad, India21+ Years experience
Why consider this doctor?
- 21+ years of experience in Medical Oncologist
- Senior Consultant — Medical Oncology, Yashoda Hospitals, Hi-Tech City, Hyderabad (Present)
- Consultant — Medical Oncology, American Oncology Institute, Hyderabad
Expertise & Procedures
- Chemotherapy Administration for Solid and Hematological Cancers
- Targeted Therapy and Molecular Cancer Treatment
- Cancer Immunotherapy and Checkpoint Inhibitors
- Stem Cell Transplantation
- Bone Marrow Transplantation
Medical Oncologist Experience: 21+ YearsHospital Affiliation: Yashoda Hospitals, Hi-Tech CityHospital accreditation: NABH, NABL
Dr. Viraj Nevrekar
DM in Medical Oncology, MD in Medicine, ECMO Certification
Senior Consultant — Medical Oncology & Bone Marrow Transplant · Specialty: Medical Oncologist & Hemato-Oncologist
Gleneagles Global Hospitals Mumbai, India11+ Years experience
Why consider this doctor?
- 11+ years of experience in Medical Oncologist & Hemato-Oncologist
- Senior Consultant — Medical Oncology & Bone Marrow Transplant, Gleneagles Global Hospitals, Mumbai, Parel
- Over 11 years of clinical practice in medical oncology and hemato-oncology across leading Indian hospital networks
Expertise & Procedures
- Allogeneic Bone Marrow Transplantation
- Autologous Stem Cell Transplantation
- High-dose Chemotherapy Regimens
- Cancer Immunotherapy and CAR-T Cell Therapy
- Targeted Molecular Therapy for Solid Tumors
Medical Oncologist & Hemato-Oncologist Experience: 11+ YearsHospital Affiliation: Gleneagles Global HospitalsHospital accreditation: NABH, JCI
Hospitals where these doctors practise
🇮🇳 Gurgaon, IndiaStarting from$18,000
Medanta - The Medicity
Est. 2009
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
4+
Doctors for Autologous Stem Cell Transplantation
4.9
2150 reviews
1600+
Beds
17+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$18,000
Artemis Hospital
Est. 2007
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
1+
Doctors for Autologous Stem Cell Transplantation
4.9
64 reviews
750+
Beds
19+
Years Since Founded
🇮🇳 Gurgaon, IndiaStarting from$18,000
Fortis Memorial Research Institute
Est. 1996
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
3+
Doctors for Autologous Stem Cell Transplantation
4.8
1100 reviews
1000+
Beds
30+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$18,000
Fortis Escorts Heart Institute
Est. 1988
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
1+
Doctors for Autologous Stem Cell Transplantation
4.5
24 reviews
310+
Beds
38+
Years Since Founded
🇮🇳 Parel, Mumbai, IndiaStarting from$18,000
Gleneagles Global Hospitals (Global Hospitals)
Est. 1996
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationJCI — Joint Commission International accreditation
Autologous Stem Cell TransplantationLiver TransplantCardiac SurgeryOrthopedics
3+
Doctors for Autologous Stem Cell Transplantation
4.6
183 reviews
450+
Beds
30+
Years Since Founded
🇮🇳 Hitec City, Hyderabad, IndiaStarting from$18,000
Medicover Hospital Hitec City
Est. 2011
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
2+
Doctors for Autologous Stem Cell Transplantation
4.3
95 reviews
250+
Beds
15+
Years Since Founded
🇮🇳 New Delhi, IndiaStarting from$18,000
Apollo Hospitals
Est. 1983
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyMedical Oncology
2+
Doctors for Autologous Stem Cell Transplantation
4.9
1240 reviews
1000+
Beds
43+
Years Since Founded
🇮🇳 Mira Road, Mumbai, IndiaStarting from$18,000
Wockhardt Super Speciality Hospital
Est. 2014
NABH — National Accreditation Board for Hospitals & Healthcare Providers accreditationNABL — National Accreditation Board for Testing and Calibration Laboratories accreditation
Autologous Stem Cell TransplantationCardiac SciencesOrthopedicsNeurosciences
1+
Doctors for Autologous Stem Cell Transplantation
4.4
48 reviews
350+
Beds
12+
Years Since Founded
🇮🇳 Mumbai, IndiaStarting from$18,000
Apollo Hospitals, Navi Mumbai
Est. 2016
JCI — Joint Commission International accreditationNABH — National Accreditation Board for Hospitals & Healthcare Providers accreditation
Autologous Stem Cell TransplantationCardiac SurgeryCardiologyOncology
1+
Doctors for Autologous Stem Cell Transplantation
4.8
512 reviews
500+
Beds
10+
Years Since Founded
Why consider treatment in India?
Many international patients consider India for multiple myeloma treatment for several reasons, including:
More affordable estimates
Competitive indicative costs compared with many other countries, for similar clinical standards.
Internationally accredited hospitals
Hospitals experienced in treating international patients.
Experienced specialists
Doctors who regularly manage similar cases.
Care coordination support
A team to help with planning, medical translation and follow-up.
About the Procedure
What is Autologous Stem Cell Transplantation?
Autologous Stem Cell Transplantation (ASCT) is a treatment for multiple myeloma and certain other blood cancers in which a patient's own stem cells are collected, high-dose chemotherapy is given to destroy diseased bone marrow, and the stored stem cells are then reinfused to rebuild healthy marrow function. It is considered a standard-of-care consolidation therapy for eligible myeloma patients after initial induction chemotherapy, aiming to achieve deeper and longer-lasting disease remission. India offers this procedure at leading BMT centers with internationally trained hematologists at a fraction of Western costs.
Who may be considered?
Autologous Stem Cell Transplantation may be considered after a qualified specialist reviews your reports and medical history. Suitability varies from person to person and must be assessed by your treating doctor.
How does it work?
Stem cells are mobilized from bone marrow into the bloodstream using growth factors (with or without chemotherapy priming), collected via apheresis, and reinfused after high-dose melphalan conditioning.
Peripheral Blood Stem Cell Mobilization & Transplant
Most CommonStem cells are mobilized from bone marrow into the bloodstream using growth factors (with or without chemotherapy priming), collected via apheresis, and reinfused after high-dose melphalan conditioning.
Comprehensive Investigations
Estimated cost: $800 - $2,000
CBC, kidney and liver function tests, bone marrow biopsy and aspirate, skeletal survey/whole body MRI, echocardiogram, ECG, pulmonary function test, viral serology (HIV, Hepatitis B/C), HLA typing (if allogeneic considered), serum protein electrophoresis, beta-2 microglobulin
Treatment / Procedure Estimate
Estimated cost in India: $18,000 - $30,000
Stay in India
Pre-procedure stay (outside hospital): ~5-7 days
Hospitalisation: ~18-21 days
Recovery period (outside hospital): ~30-45 days recommended
Total stay: approx 45-60 days
Usually Included in Hospital Package
- Stem cell mobilization and apheresis collection
- High-dose chemotherapy conditioning
- Stem cell reinfusion and inpatient isolation care
- Nursing and hematologist consultations
- Blood product support (transfusions)
- Basic post-transplant follow-up visits
Usually Not Included
- Long-term immunosuppressive or maintenance therapy medications
- Extended ICU stay in case of complications
- Travel, visa, and accommodation for attendants
- Additional imaging for relapse monitoring
- International second opinions
Recovery and follow-up
Most patients remain hospitalized for 2-3 weeks post-transplant until blood counts recover, followed by 4-6 weeks of home recovery with close monitoring for infections before returning to normal activities.
Risks
Potential risks include infection due to temporary immune suppression, mucositis, nausea, bleeding, organ toxicity from high-dose chemotherapy, and in rare cases graft failure or transplant-related mortality.
Alternatives
Alternatives include continued conventional chemotherapy without transplant, novel targeted or immunotherapy regimens (e.g., monoclonal antibodies, CAR-T therapy), or allogeneic stem cell transplantation in select high-risk cases.
What we need to prepare a formal estimate
Share whatever you have — the care team will confirm the final checklist after reviewing your case.
Reports required
- Recent bone marrow biopsy and aspirate report
- Complete blood count (CBC) and comprehensive metabolic panel
- Serum protein electrophoresis and free light chain assay results
- Skeletal survey or whole-body MRI/CT findings
- Echocardiogram and ECG reports
- Previous chemotherapy/induction treatment history and response
- Viral serology reports (HIV, Hepatitis B and C)
- Referring hematologist's summary letter
Patient information needed
- Confirmed diagnosis stage and subtype of multiple myeloma
- Current age, weight, and overall performance status
- Details of prior induction chemotherapy cycles and response
- Any existing kidney, heart, or lung comorbidities
- Current medications and allergy history
- Availability of a caregiver/attendant for the hospital stay
- Insurance or payment method for treatment
Costs shown are indicative planning estimates based on typical pricing across leading Indian hospitals. They are not a quote — actual pricing depends on your case complexity, hospital choice, and length of stay. Share your reports for a personalized estimate.
How this directory is built
Doctors are matched using the specialty, location, condition (Autologous Stem Cell Transplantation) and procedure (Autologous Stem Cell Transplantation) recorded in their profiles. Inclusion is not an endorsement and does not guarantee a treatment outcome.
Need help with the next step?
Share your needs with our care coordination team for information about doctors and hospitals.
Common questions
FAQs about Autologous Stem Cell Transplantation in India
What is Multiple Myeloma?
Multiple myeloma is a cancer in which abnormal plasma cells accumulate in the bone marrow, producing excess proteins (called M-proteins or paraproteins) that can damage organs and disrupt normal blood cell production. It is considered a haematological malignancy and, while not currently curable in most cases, it is treatable and can often be managed effectively for many years.
What are the symptoms and health risks of Multiple Myeloma?
Common symptoms include persistent bone pain (particularly in the back, ribs, or hips), unexplained fatigue, frequent infections, easy bruising or bleeding, and signs of kidney problems such as increased thirst or reduced urine output. Some people experience numbness or weakness in the limbs if the disease affects the spine, and elevated calcium levels can cause confusion, nausea, or constipation. These symptoms overlap with many other conditions, and their presence alone is not sufficient to establish a diagnosis of multiple myeloma.
How is Multiple Myeloma diagnosed?
Diagnosis typically involves blood and urine tests to detect abnormal proteins (including serum protein electrophoresis, immunofixation, and free light chain assay), a full blood count, kidney and calcium level checks, and bone marrow biopsy to confirm the presence and proportion of malignant plasma cells. Imaging — such as whole-body low-dose CT, MRI, or PET-CT — is used to assess bone involvement and detect lesions. Disease severity is stratified using established staging systems such as the Revised International Staging System (R-ISS), which incorporates albumin, beta-2 microglobulin, LDH levels, and cytogenetic risk markers to guide prognosis and treatment decisions.
How is Multiple Myeloma treated?
Treatment is highly individualised and depends on factors including disease stage, cytogenetic risk profile, the patient's age, fitness, and organ function. For eligible patients, high-dose chemotherapy followed by autologous stem cell transplantation (using the patient's own stem cells) is a standard approach that can deepen and prolong remission. Alongside or instead of transplant, treatment may include combinations of targeted therapies (such as proteasome inhibitors or IMiDs), immunotherapy (including monoclonal antibodies), and conventional chemotherapy, with the specific regimen determined by a qualified specialist based on individual assessment.
Can Multiple Myeloma be treated without a procedure?
For patients who are not eligible for stem cell transplantation — due to age, fitness level, or other health conditions — effective non-procedural management is available using combinations of oral or intravenous targeted agents, immunotherapy, and chemotherapy. Supportive care measures, including bisphosphonates to protect bone health, growth factors to address anaemia, and prophylactic antibiotics to reduce infection risk, form an important part of ongoing management for all patients regardless of transplant eligibility. Active monitoring (sometimes called 'watch and wait') may be appropriate for asymptomatic precursor states such as smouldering myeloma, but this decision must be made by a specialist following careful individual assessment.
When is Autologous Stem Cell Transplantation considered for Multiple Myeloma?
Autologous Stem Cell Transplantation may be considered only when it is appropriate for the confirmed diagnosis and the expected benefit outweighs the individual risks. The decision may depend on symptom severity, investigation results, previous treatment, overall health and the patient's goals. A specialist should discuss alternatives and recovery before any procedure is planned.
Which doctor treats Multiple Myeloma?
Multiple myeloma is typically evaluated and managed by a haematologist or medical oncologist with specific expertise in haematological malignancies. For patients being considered for stem cell transplantation, care is coordinated through a specialist in bone marrow transplantation, usually within a multidisciplinary team that may also include nephrologists, radiologists, and specialist nurses.
How do I choose a doctor for Multiple Myeloma?
When selecting a specialist or facility, it is worth asking about the centre's volume and experience specifically in treating multiple myeloma, whether they offer access to a full multidisciplinary team, availability of novel and clinical-trial therapies, and what structured follow-up and relapse monitoring looks like over the long term.
What documents do international patients need to share for a medical evaluation?
Share a concise medical summary, symptom timeline, previous diagnoses, investigation and imaging reports, procedure or biopsy reports where relevant, current medicines, allergies and related treatment records. Provide clear copies with translations when needed. The reviewing doctor may request additional information before giving an opinion.
How does GAF Healthcare help international patients plan treatment in India?
Our care coordination team can review the initial information, help identify suitable doctors and hospitals, request a medical opinion where available, explain next steps and indicative cost information, and support practical planning before travel. A remote opinion does not replace an in-person examination or emergency care.